The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.
The European Medicines Agency (EMA) has granted AstraZeneca's (AZ) COVID-19 vaccine, Vaxzevria – ChAdOx1-S [Recombinant] – full Marketing Authorisation (MA) in the EU.
The vaccine was well-tolerated and no safety concerns were observed. For the prevention of RSV disease in newborns and children, AstraZeneca and Sanofi’s Beyfortus (nirsevimab) was recommended for conditional
Alexion’s – part of the AstraZeneca Rare Disease group – Ultomiris (ravulizumab) significantly reduced relapse risk in adults with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) compared to an
Both trials showed significant improvement in progression-free survival. AstraZeneca (AZ) has announced positive high-level results from two individual advanced breast cancer trials evaluating both its next-generation oral selective
AstraZeneca’s Imjudo (tremelimumab) – an anti-CTLA4 antibody – in combination with Imfinzi (durvalumab) – an anti-PD-L1 antibody – has been approved by the US Food and Drug Administration (FDA) for the
[ Previous 5 results ] 8 9 10 11 12 13 14 15 16 17 [ Next 5 results ]
No results were found
Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...